// App-Quantinova.ai

FRI0337 (2018) : Factors associated with poor therapeutic adherence to hydroxychloroquine during systemic lupus

Researchers

Presenter

  • Y. Rozban

Principal Investigators

  • H. Devilliers

  • M. Hié

  • M. Pha

  • A. Mathian

  • F. Cohen-Aubart

  • J. Haroche

  • J.-S. Hulot

  • N. Zahr

  • Z. Amoura

Medical Centers

  • French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Assistance Publique–Hôpitaux de Paris (APHP, Groupement Hospitalier Pitié–Salpêtrière

  • Médecine Interne et Maladies Systémiques – Médecine 2, CHU Dijon, Dijon

  • Pharmacologie biologique, Hôpital universitaire Pitié-Salpêtrière, PARIS, France

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved